The discovery of microRNA (miRNA) significantly extends our knowledge on gene regulation and noncoding gene functions. MiRNAs are important post-transcriptional regulators involve in a wide range of biological functions and diseases, including cancer. MiRNAs are produced by a unique biogenesis pathway involving the two-step sequential nuclear and cytoplasmic RNase-dependent processing at post-transcriptional level. However, a specific (set) of miRNA(s) is (are) synthesized under certain circumstance or developmental/pathological stage to fine-tune the gene expression profile. In this minireview, we will discuss the mechanism of miRNA biogenesis in cancer, mainly focusing on how Drosha and Dicer, two critical molecules controlling miRNA biogenesis, are modulated and which factor contributes to the specificity of selected miRNA maturation.
Impact statement
The canonical maturation pathway of miRNAs is highly conserved, indicating the crucial roles of these mini-regulators in most cellular processes. Dysregulation of specific miRNAs or imbalance of miRNA abundance has been observed in cancers. Accumulating evidence has shown that the interplay between miRNA processing factors and regulatory proteins previously known as key players in cancer malignancy regulates the biogenesis of miRNAs, expression of target genes, and eventually the alteration of cellular phenotypes. This minireview summarizes the current findings in the modulation of miRNA biogenesis in cancer to advance the understanding of how noncoding RNA contributes to cancer development and malignancy.
HutvagnerGMcLachlanJPasquinelliAEBalintETuschlTZamorePD.A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science2001;
293:834–8
2.
FukunagaRHanBWHungJHXuJWengZZamorePD.Dicer partner proteins tune the length of mature miRNAs in flies and mammals. Cell2012;
151:912
3.
BernsteinECaudyAAHammondSMHannonGJ.Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature2001;
409:363–6
4.
ChendrimadaTPGregoryRIKumaraswamyENormanJCoochNNishikuraKShiekhattarR.TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature2005;
436:740–4
5.
MacraeIJZhouKLiFRepicABrooksANCandeWZAdamsPDDoudnaJA.Structural basis for double-stranded RNA processing by Dicer. Science2006;
311:195–8
6.
LauPWGuileyKZDeNPotterCSCarragherBMacRaeIJ.The molecular architecture of human Dicer. Nat Struct Mol Biol2012;
19:436–40
7.
KobayashiHTomariY.RISC assembly: coordination between small RNAs and argonaute proteins. Biochim Biophys Acta2016;
1859:71–81
8.
FabianMRSonenbergNFilipowiczW.Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem2010;
79:351–79
9.
IwakawaHOTomariY.The functions of MicroRNAs: mRNA decay and translational repression. Trends Cell Biol2015;
25:651–65
10.
NegriniMFerracinMSabbioniSCroceCM.MicroRNAs in human cancer: from research to therapy. J Cell Sci2007;
120:1833–40
11.
LuJGetzGMiskaEAAlvarez-SaavedraELambJPeckDSweet-CorderoAEbertBLMakRHFerrandoAADowningJRJacksTHorvitzHRGolubTR.MicroRNA expression profiles classify human cancers. Nature2005;
435:834–8
12.
LinSGregoryRI.MicroRNA biogenesis pathways in cancer. Nat Rev Cancer2015;
15:321–33
13.
JohansonTMLewAMChongMM.MicroRNA-independent roles of the RNase III enzymes Drosha and Dicer. Open Biol2013;
3:130144
14.
TorrezanGTFerreiraENNakahataAMBarrosBDCastroMTCorreaBRKrepischiACOlivieriEHCunhaIWTaboriUGrundyPECostaCMde CamargoBGalantePACarraroDM.Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour. Nat Commun2014;
5:4039
15.
RakhejaDChenKSLiuYShuklaAASchmidVChangTCKhokharSWickiserJEKarandikarNJMalterJSMendellJTAmatrudaJF.Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours. Nat Commun2014;
2:4802
16.
WegertJIshaqueNVardapourRGeorgCGuZBiegMZieglerBBausenweinSNourkamiNLudwigNKellerAGrimmCKneitzSWilliamsRDChagtaiTPritchard-JonesKvan SluisPVolckmannRKosterJVersteegRAchaTO’SullivanMJBodePKNiggliFTytgatGAvan TinterenHvan den Heuvel-EibrinkMMMeeseEVokuhlCLeuschnerIGrafNEilsRPfisterSMKoolMGesslerM.Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell2015;
27:298–311
17.
KruberPAngayOWinklerABoslMRKneitzSHeinzeKGGesslerM.Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation. Int J Cancer2019;
144:1391–400
18.
HillDAIvanovichJPriestJRGurnettCADehnerLPDesruisseauDJarzembowskiJAWikenheiser-BrokampKASuarezBKWhelanAJWilliamsGBracamontesDMessingerYGoodfellowPJ.DICER1 mutations in familial pleuropulmonary blastoma. Science2009;
325:965
19.
DorosLARossiCTYangJFieldAWilliamsGMMessingerYCajaibaMMPerlmanEJ, KACathroHPLegalloRDLaFortuneKAChikwavaKRFariaPGellerJIDomeJSMullenEAGratiasEJDehnerLPHillDA.DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol2014;
27:1267–80
20.
de KockLSabbaghianNPlourdeFSrivastavaAWeberEBouron-Dal SoglioDHamelNChoiJHParkSHDealCLKelseyMMDishopMKEsbenshadeAKutteschJFJacquesTSPerryALeichterHMaederPBrundlerMAWarnerJNealJZacharinMKorbonitsMColeTTrauneckerHMcLeanTWRotondoFLepagePAlbrechtSHorvathEKovacsKPriestJRFoulkesWD.Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol2014;
128:111–22
21.
DorosLYangJDehnerLRossiCTSkiverKJarzembowskiJAMessingerYSchultzKAWilliamsGAndreNHillDA.DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome. Pediatr Blood Cancer2012;
59:558–60
22.
Heravi-MoussaviAAnglesioMSChengSWSenzJYangWPrenticeLFejesAPChowCToneAKallogerSEHamelNRothAHaGWanANMaines-BandieraSSalamancaCPasiniBClarkeBALeeAFLeeCHZhaoCYoungRHAparicioSASorensenPHWooMMBoydNJonesSJHirstMMarraMAGilksBShahSPFoulkesWDMorinGBHuntsmanDG.Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med2012;
366:234–42
23.
SchultzKAPachecoMCYangJWilliamsGMMessingerYHillDADehnerLPPriestJR.Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the international pleuropulmonary blastoma registry. Gynecol Oncol2011;
122:246–50
de KockLDrukerHWeberEHamelNTraubiciJMalkinDArseneauJStewartCJBouron-Dal SoglioDPriestJRFoulkesWD.Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome. Hum Pathol2015;
46:917–22
26.
RupaimooleRWuSYPradeepSIvanCPecotCVGharpureKMNagarajaASArmaiz-PenaGNMcGuireMZandBDaltonHJFilantJMillerJBLuCSadaouiNCMangalaLSTaylorMvan den BeuckenTKochERodriguez-AguayoCHuangLBar-EliMWoutersBGRadovichMIvanMCalinGAZhangWLopez-BeresteinGSoodAK.Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun2014;
5:5202
27.
van den BeuckenTKochEChuKRupaimooleRPrickaertsPAdriaensMVonckenJWHarrisALBuffaFMHaiderSStarmansMHWYaoCQIvanMIvanCPecotCVBoutrosPCSoodAKKoritzinskyMWoutersBG.Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat Commun2014;
5:5203
28.
SuXChakravartiDChoMSLiuLGiYJLinYLLeungMLEl-NaggarACreightonCJSuraokarMBWistubaIFloresER.TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature2010;
467:986–90
29.
FurlerRLNixonDFBrantnerCAPopratiloffAUittenbogaartCH.TGF-beta sustains tumor progression through biochemical and mechanical signal transduction. Cancers2018;
10:199
30.
JanakiramanHHouseRPGangarajuVKDiehlJAHowePHPalanisamyV.The long (lncRNA) and short (miRNA) of it: TGFbeta-mediated control of RNA-binding proteins and noncoding RNAs. Mol Cancer Res2018;
16:567–79
31.
DavisBNHilyardACLagnaGHataA.SMAD proteins control DROSHA-mediated microRNA maturation. Nature2008;
454:56–61
32.
DavisBNHilyardACNguyenPHLagnaGHataA.Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell2010;
39:373–84
33.
JoergerACFershtAR.The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches. Annu Rev Biochem2016;
85:375–404
34.
HeLHeXLimLPde StanchinaEXuanZLiangYXueWZenderLMagnusJRidzonDJacksonALLinsleyPSChenCLoweSWClearyMAHannonGJ.A microRNA component of the p53 tumour suppressor network. Nature2007;
447:1130–4
35.
ChangTCWentzelEAKentOARamachandranKMullendoreMLeeKHFeldmannGYamakuchiMFerlitoMLowensteinCJArkingDEBeerMAMaitraAMendellJT.Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell2007;
26:745–52
36.
TarasovVJungPVerdoodtBLodyginDEpanchintsevAMenssenAMeisterGHermekingH.Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle2007;
6:1586–93
37.
SuzukiHIYamagataKSugimotoKIwamotoTKatoSMiyazonoK.Modulation of microRNA processing by p53. Nature2009;
460:529–33
38.
ChangJDavis-DusenberyBNKashimaRJiangXMaratheNSessaRLouieJGuWLagnaGHataA.Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress. EMBO J2013;
32:3192–205
39.
SemenzaGL.Targeting HIF-1 for cancer therapy. Nat Rev Cancer2003;
3:721–32
40.
LinSCLiaoWLLeeJCTsaiSJ.Hypoxia-regulated gene network in drug resistance and cancer progression. Exp Biol Med2014;
239:779–92
41.
LiaoWLLinSCSunHSTsaiSJ.Hypoxia-induced tumor malignancy and drug resistance: role of microRNAs. Biomark Genom Med2014;
6:1–11
42.
HuJSunTWangHChenZWangSYuanLLiuTLiHRWangPFengYWangQMcLendonREFriedmanAHKeirSTBignerDDRathmellJFuXDLiQJWangHWangXF.MiR-215 is induced post-transcriptionally via HIF-Drosha complex and mediates glioma-initiating cell adaptation to hypoxia by targeting KDM1B. Cancer Cell2016;
29:49–60
43.
LaiHHLiJNWangMYHuangHYCroceCMSunHLLyuYJKangJWChiuCFHungMCSuzukiHIChenPS.HIF-1alpha promotes autophagic proteolysis of Dicer and enhances tumor metastasis. J Clin Invest2018;
128:625–43
44.
GherziRLeeKYBriataPWegmullerDMoroniCKarinMChenCY.A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol Cell2004;
14:571–83
45.
Garcia-MayoralMFHollingworthDMasinoLDiaz-MorenoIKellyGGherziRChouCFChenCYRamosA.The structure of the C-terminal KH domains of KSRP reveals a noncanonical motif important for mRNA degradation. Structure2007;
15:485–98
46.
TrabucchiMBriataPGarcia-MayoralMHaaseADFilipowiczWRamosAGherziRRosenfeldMG.The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature2009;
459:1010–4
47.
ZhangXWanGBergerFGHeXLuX.The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol Cell2011;
41:371–83
48.
YuanHDengRZhaoXChenRHouGZhangHWangYXuMJiangBYuJ.SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis. Mol Cancer2017;
16:157
49.
GuilSCaceresJF.The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol2007;
14:591–6
50.
TsangWPKwokTT.The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis2009;
30:953–9
51.
MichlewskiGCaceresJF.Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat Struct Mol Biol2010;
17:1011–8
52.
JohnsonSMGrosshansHShingaraJByromMJarvisRChengALabourierEReinertKLBrownDSlackFJ.RAS is regulated by the let-7 microRNA family. Cell2005;
120:635–47
53.
KimMSlackFJ.MicroRNA-mediated regulation of KRAS in cancer. J Hematol Oncol2014;
7:84
54.
ZhangJXuAMiaoCYangJGuMSongN.Prognostic value of Lin28A and Lin28B in various human malignancies: a systematic review and meta-analysis. Cancer Cell Int2019;
19:79
55.
HeoIJooCChoJHaMHanJKimVN.Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell2008;
32:276–84
56.
HeoIJooCKimYKHaMYoonMJChoJYeomKHHanJKimVN.TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell2009;
138:696–708
57.
ViswanathanSRDaleyGQGregoryRI.Selective blockade of microRNA processing by Lin28. Science2008;
320:97–100
58.
PiskounovaEPolytarchouCThorntonJELaPierreRJPothoulakisCHaganJPIliopoulosDGregoryRI.Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell2011;
147:1066–79
59.
NewmanMAThomsonJMHammondSM.Lin-28 interaction with the let-7 precursor loop mediates regulated microRNA processing. RNA2008;
14:1539–49
60.
RybakAFuchsHSmirnovaLBrandtCPohlEENitschRWulczynFG.A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol2008;
10:987–93
61.
ChenYXieCZhengXNieXWangZLiuHZhaoY.LIN28/let-7/PD-L1 pathway as a target for cancer immunotherapy. Cancer Immunol Res2019;
7:487–97
62.
NishikuraK.A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol2016;
17:83–96
63.
NemlichYGreenbergEOrtenbergRBesserMJBarshackIJacob-HirschJJacobyEEyalERivkinLPrietoVGChakravartiNDuncanLMKallenbergDMGalunEBennettDCAmariglioNBar-EliMSchachterJRechaviGMarkelG.MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest2013;
123:2703–18
64.
TassinariVCesariniVSilvestrisDAGalloA.The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer. Biochim Biophys Acta Gene Regul Mech2019;
1862:291–300
